An Australian obstetrician first warned the world of the dangers posed to unborn babies by the (then) widely prescribed maternal anti-nausea drug Thalidomide. Australia was relatively slow to halt its use – with devastating consequences still being felt decades on.
Today, despite warnings from clinicians in Australia and abroad, Australia risks repeating the same mistake over the medical treatment of children questioning their gender identity or suffering from gender dysphoria.
NSW Health Minister Brad Hazzard, John Hunter Hospital in Newcastle, and Maple Leaf House Transgender and Gender Diversity Clinic for children were all scrutinised by committee chair Greg Donnelly in the Budget Estimates Hearing...
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in